Clinical trial
A Study to Test Whether Different Doses of BI 1291583 Help People With…
NCT05238675 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT05238675 |
|---|---|
| Title | A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis |
| Official title | A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-finding Study Evaluating Efficacy, Safety and Tolerability of BI 1291583 qd Over at Least 24 Weeks in Patients With Bronchiectasis (AirleafTM) |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bronchiectasis |
| Intervention type | Drug |
| Interventions | BI 1291583, Placebo |
| Enrollment | 322 |
| Start date | Apr 28, 2022 |
| Primary completion | May 1, 2024 |
| Completion | May 30, 2024 |
| First posted | Feb 14, 2022 |
| Last update posted | Aug 14, 2025 |
| Countries | Australia, Belgium, Bulgaria, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy and 11 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: